AstraZeneca's vaccine found to be 79% effective, with no safety issues, in U.S. trial
AstraZeneca's vaccine found to be 79% effective, with no safety issues, in U.S. trial Henry Chu © Provided by The LA Times A nurse prepares a dose of the AstraZeneca COVID-19 vaccine in Lyon, France. (Associated Press) AstraZeneca's vaccine was 79% effective at preventing any COVID-19 symptoms and 100% at preventing severe ones, and had no safety issues with blood clots in large-scale U.S. trials, the company said Monday. The results of the trials involving 32,449 people pave the way for AstraZeneca to apply for emergency-use authorization in the United States. The vaccine ...